FOLR2 and neoplasm: Further, as the tumor microenvironment (TME) has emerged as an important determinant of disease progression for EOC, it is notable that tumor-associated macrophages (TAMs) express FRβ, thus providing new opportunities to suppress ovarian tumor progression by inhibiting TAMs with FR-targeted therapies [15,16,17,18].